At the American Society of Hematology (ASH) meeting in Philadelphia on Monday, Michael Pfreundschuh of Saarland University Medical School in Homburg, Germany presented similar data showing that closer dosing of chemotherapy was also helpful in non-Hodgkin's lymphoma.